HIT (Hepatitis C Inoculum Trial)
No. of participants: 10
Oxford based
Duration: six months
What is the purpose of this study and why participate?
There is currently no vaccine for hepatitis C virus (HCV), and it is not feasible to conduct large clinical trials of new vaccines in naturally infected people. A Controlled Human Infection Model (CHIM) where healthy volunteers are intentionally exposed to HCV would allow more efficient testing of new preventative vaccines or drugs.
Trial Information
REC reference: 25/SC/0383
Chief Investigator: Eleanor Barnes
Do you have a question?
Aims and outcomes
The purpose of this study is to collect blood from individuals with acute (short-term) and chronic (long-term) HCV infection. The plasma, which contains HCV, will be separated from the blood, tested, and stored for later use to establish HCV infection in future ethically-approved carefully monitored CHIM studies.
Location
The University of Oxford Experimental Medicine Clinical Research Facility (EMCRF)
Team
Partners
